These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: New tumor necrosis factor-alpha biologic therapies for rheumatoid arthritis.
    Author: Breedveld F.
    Journal: Eur Cytokine Netw; 1998 Sep; 9(3):233-8. PubMed ID: 9831171.
    Abstract:
    Continued research towards new and better tolerated therapies to attenuate the inflammation and pain associated with rheumatoid arthritis and to halt the progression of erosive joint damage has led to the development of anticytokine strategies. Of these therapies, the most promising appear to be those targeted towards blocking the effects of TNF-alpha. Trials with etanercept, which showed significant, rapid and sustained reductions in disease activity, have produced particularly encouraging results.
    [Abstract] [Full Text] [Related] [New Search]